2
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Sleep-disordered breathing, sleep apnea, and other obesity-related sleep disorders: An Obesity Medicine Association (OMA) Clinical Practice Statement (CPS) 2022

      other

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Background

          This Obesity Medicine Association (OMA) Clinical Practice Statement (CPS) provides clinicians an overview of sleep-disordered breathing, (e.g., sleep-related hypopnea, apnea), and other obesity-related sleep disorders.

          Methods

          The scientific support for this CPS is based upon published citations, clinical perspectives of OMA authors, and peer review by the Obesity Medicine Association leadership.

          Results

          Obesity contributes to sleep-disordered breathing, with the most prevalent manifestation being obstructive sleep apnea. Obesity is also associated with other sleep disorders such as insomnia, primary snoring, and restless legs syndrome. This CPS outlines the evaluation, diagnosis, and treatment of sleep apnea and other sleep disorders, as well as the clinical implications of altered circadian system.

          Conclusions

          This Obesity Medicine Association (OMA) Clinical Practice Statement (CPS) on “Sleep-Disordered Breathing, Sleep Apnea, and Other Obesity-Related Sleep Disorders” is one of a series of OMA CPSs designed to assist clinicians in the care of patients with the disease of obesity.

          Related collections

          Most cited references67

          • Record: found
          • Abstract: found
          • Article: not found

          Clinical Practice Guideline for the Pharmacologic Treatment of Chronic Insomnia in Adults: An American Academy of Sleep Medicine Clinical Practice Guideline.

          The purpose of this guideline is to establish clinical practice recommendations for the pharmacologic treatment of chronic insomnia in adults, when such treatment is clinically indicated. Unlike previous meta-analyses, which focused on broad classes of drugs, this guideline focuses on individual drugs commonly used to treat insomnia. It includes drugs that are FDA-approved for the treatment of insomnia, as well as several drugs commonly used to treat insomnia without an FDA indication for this condition. This guideline should be used in conjunction with other AASM guidelines on the evaluation and treatment of chronic insomnia in adults.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Diagnosis and Management of Obstructive Sleep Apnea: A Review

            Obstructive sleep apnea (OSA) affects 17% of women and 34% of men in the US and has a similar prevalence in other countries. This review provides an update on the diagnosis and treatment of OSA.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Brief communication: Sleep curtailment in healthy young men is associated with decreased leptin levels, elevated ghrelin levels, and increased hunger and appetite.

              Total sleep deprivation in rodents and in humans has been associated with hyperphagia. Over the past 40 years, self-reported sleep duration in the United States has decreased by almost 2 hours. To determine whether partial sleep curtailment, an increasingly prevalent behavior, alters appetite regulation. Randomized, 2-period, 2-condition crossover clinical study. Clinical Research Center, University of Chicago, Chicago, Illinois. 12 healthy men (mean age [+/-SD], 22 +/- 2 years; mean body mass index [+/-SD], 23.6 +/- 2.0 kg/m2). Daytime profiles of plasma leptin and ghrelin levels and subjective ratings of hunger and appetite. 2 days of sleep restriction and 2 days of sleep extension under controlled conditions of caloric intake and physical activity. Sleep restriction was associated with average reductions in the anorexigenic hormone leptin (decrease, 18%; P = 0.04), elevations in the orexigenic factor ghrelin (increase, 28%; P < 0.04), and increased hunger (increase, 24%; P < 0.01) and appetite (increase, 23%; P = 0.01), especially for calorie-dense foods with high carbohydrate content (increase, 33% to 45%; P = 0.02). The study included only 12 young men and did not measure energy expenditure. Short sleep duration in young, healthy men is associated with decreased leptin levels, increased ghrelin levels, and increased hunger and appetite.
                Bookmark

                Author and article information

                Contributors
                Journal
                Obes Pillars
                Obes Pillars
                Obesity Pillars
                Elsevier
                2667-3681
                15 November 2022
                December 2022
                15 November 2022
                : 4
                : 100043
                Affiliations
                [a ]Chair and Associate Professor of Family Medicine, Campbell University School of Osteopathic Medicine, Buies Creek, NC, 27506, USA
                [b ]Watertown Family Practice, Clinical Preceptor, University of Wisconsin Family Medicine Residency, Madison, WI, USA
                [c ]Division of Hospitalist Medicine, Bassett Healthcare Network, Assistant Clinical Professor of Medicine Columbia University, 1 Atwell Road, Cooperstown, NY, 13326, USA
                [d ]Department of Family and Community Medicine, Penn State Health, Penn State College of Medicine 700 HMC Crescent Rd Hershey, PA, 17033, USA
                [e ]Louisville Metabolic and Atherosclerosis Research Center, Clinical Associate Professor, University of Louisville School of Medicine, 3288 Illinois Avenue, Louisville, KY, 40213, USA
                Author notes
                []Corresponding author. Louisville Metabolic and Atherosclerosis Research Center, University of Louisville School of Medicine, 3288 Illinois Avenue, Louisville, KY, 40213, USA.
                Article
                S2667-3681(22)00034-1 100043
                10.1016/j.obpill.2022.100043
                10662058
                37990672
                b9efc8a9-0a81-4c61-920f-9aaf6855aad1
                © 2022 The Authors

                This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).

                History
                : 10 November 2022
                : 10 November 2022
                Categories
                Review

                clinical practice statement,obesity,pre-obesity,sleep apnea,sleep disorders

                Comments

                Comment on this article